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[potassium channels,]{.smallcaps} particularly the voltage-dependent potassium channels (Kv), are inherently involved in the physiological maintenance of the pulmonary vasculature. Prominent roles in the maintenance of resting membrane potential, cell migration, proliferation, and contractility have all been well documented ([@r4], [@r33], [@r50], [@r51]). Inhibition of Kv channels is widely accepted to occur in response to low oxygen tension in the pulmonary arteries ([@r3], [@r30], [@r36], [@r52]) resulting in depolarization and opening of voltage-dependent Ca^2+^ channels leading to calcium influx and elevated intracellular calcium concentrations.

Oxygen-sensing capability of the mitochondria.
==============================================

Given that the function of the pulmonary vasculature is for reoxygenation of the blood supply to the systemic circulation, the arteries are exposed to a highly oxygenated environment. Pulmonary arteries are sensitive to changes in the oxygen tension and respond uniquely by contracting in response to periods of low oxygen tension (hypoxia) ([@r1], [@r26]). How changes in oxygen tension are detected and translated into such a functional response remains complex and is presently still not fully determined.

The mitochondria are considered to be prominent oxygen-sensing cellular organelles due to their demand on oxygen to generate ATP as a source of cellular chemical energy. There is evidence suggesting that Kv channels may be regulated by mitochondria-dependent changes in intracellular redox state. With respect to the hypoxia-mediated inhibition of Kv channel currents (*I*~Kv~) in the pulmonary arteries, a role for reactive oxygen species has been demonstrated. Indeed, both oxidizing ([@r31], [@r37]) and reducing ([@r31], [@r37], [@r54]) agents have been shown to respectively enhance and inhibit Kv channel currents in the pulmonary arterial smooth muscle cells (PASMCs). Inhibition of Kv channels by hypoxia would therefore require the intracellular environment to become reduced during hypoxia. This idea is central to the redox hypothesis ([@r28], [@r49]). Evidence, however, suggests that production of reactive oxygen species by mitochondria might be increased during hypoxia (reviewed in Refs. [@r47] and [@r48]), thus challenging the main concept of the redox hypothesis. This controversy may indicate that, in addition to changes in cellular redox state, other mitochondria-dependent mechanisms may also be involved in the hypoxic inhibition of the Kv channels in PASMCs. For example, incubation of PASMCs with 2-deoxyglucose, which inhibits mitochondrial function, also inhibits *I*~Kv~ ([@r53], [@r54]). Although the inhibition of the whole cell *I*~Kv~ amplitude in PASMCs by some mitochondrial electron transport chain (mETC) inhibitors and uncouplers has been reported previously ([@r3], [@r27], [@r53]), the precise mode of their action remains to be elucidated.

We ([@r45]) have previously demonstrated a potent interaction of increased intracellular magnesium with Kv channels in the vasculature. Magnesium inhibits Kv channel currents at positive potentials ([@r45]). It is possible that dysregulation of the mitochondria \[an intracellular store of magnesium ([@r10], [@r21])\] may contribute to an elevated intracellular magnesium concentration. Furthermore, ATP production by mitochondrial oxidative phosphorylation may be impeded, resulting in changes in potassium currents as ATP can also interact with Kv channels ([@r12], [@r32]).

This is a comprehensive study of the effects of mitochondrial inhibition on Kv channel currents in isolation from other major K^+^ conductances and establishes a role for mitochondria-dependent ATP and magnesium regulation in the modulation of *I*~Kv~ in PASMCs. Some of this work has been published in a preliminary form ([@r42]).

MATERIALS AND METHODS
=====================

Materials.
----------

Basic chemicals were purchased from BDH Merck (U. K.) or Fisher (U. K.). Collagenase (type XI) or collagenase P (used in more recent experiments) was obtained from Sigma or Roche, respectively. Papain and dithiothreitol used for cell isolation were purchased from Sigma (U. K.). The mitochondrial uncoupler CCCP, mETC inhibitors, rotenone, myxothiazol, antimycin A (a mixture of antimycins from *Streptomyces* species), and sodium cyanide (NaCN) were all obtained from Sigma (U. K.). MagFluo-4-AM and BAPTA-AM were purchased from Invitrogen (U. K.).

Cell isolation and electrophysiology.
-------------------------------------

Male Wistar rats (225--300 g) were killed by cervical dislocation as approved by the local U.K. Home Office inspector, and small intrapulmonary arteries (3rd--5th order) were microdissected. Isolation of PASMCs \[using 1 mg/ml collagenase (type XI), 0.5 mg/ml papain, and 1 mM dithiothreitol and 20-min incubation at 37°C\] and electrophysiological recordings were performed as previously described ([@r40], [@r46]). Freshly isolated cells were maintained on ice for use on the same day. Cells were placed in a chamber with a volume of 100--200 μl and continually superfused (∼1 ml/min) with a physiological saline solution (PSS) or a test solution via a five-barrel pipette. Experiments with sodium cyanide were performed using an agar bridge (2% agar filled with 3 M KCl) due to the presence of a diffusion potential between the reference and the pipette Ag-AgCl electrodes of more than 10 mV. This is likely to be due to a formation of water-insoluble silver cyanide on the surface of the reference electrode. PSS contained (mM): 140 NaCl, 4 KCl, 1.5 CaCl~2~, 1.2 MgCl~2~, 10 HEPES, and 10 glucose, pH 7.2. Control pipette solution contained (mM): 140 KCl, 0.5 MgCl~2~, 10 HEPES, 10 EGTA, and 0.5 CaCl~2~, pH 7.2, and was used for recording unless stated otherwise. Cells were dialyzed with pipette solution for 5 min before recording currents. The effects of inhibitors were recorded a minimum of 5 min after addition to the perfusate. All electrophysiological recordings were performed at room temperature.

*I*~Kv~ was recorded in the presence of 1 μM paxilline and 10 μM glibenclamide to block Ca^2+^-activated and ATP-sensitive K^+^ currents, respectively. This allowed analysis of the changes in the voltage-dependent characteristics of *I*~Kv~ in isolation from other potassium conductances as previously described ([@r40]). *I*~Kv~ amplitude was measured with a 200-ms voltage step applied from the holding potential of −80 mV to membrane potentials between −100 and +50 mV in 10-mV increments with frequency of 0.1 Hz. Following membrane depolarization, cells were repolarized to −20 mV for 160 ms to measure tail currents, which were used to assess changes in the steady-state activation of *I*~Kv~.

Tail currents were measured 2--3 ms after the repolarization to −20 mV. To calculate the kinetic parameters of *I*~Kv~, the *I-V* curves plotted from tail currents were fitted with the following equation $$\documentclass[10pt]{article}
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\begin{equation*}I_{{\mathrm{Kv}}(t)}=\frac{1}{1+{\mathrm{exp}}[(V_{{\mathrm{a}}}-V_{{\mathrm{m}}})/k_{{\mathrm{a}}}]}\end{equation*}\end{document}$$ where *V*~a~ and *k*~a~ are the half-activation potential and the *e*-fold steepness of the activation dependency (the slope factor of activation), respectively. Differences in the voltage dependence of *I*~Kv~ activation were assessed by comparison of the changes in half-activation potentials between control and test conditions. *I*~Kv~ block was calculated as a percentage of the current measured at the end of 200-ms depolarization to +50 mV in control conditions from the same cell. Cell membrane capacitance was measured using a 10 mV hyperpolarizing step and used to correct *I*~Kv~ currents for cell size. Therefore, currents were expressed as current density (pA/pF).

Confocal imaging of \[Mg^2+^\]~i~ in single PASMCs.
---------------------------------------------------

Changes in free \[Mg^2+^\]~i~ in single PASMCs were measured using a membrane-permeable fluorescent indicator MagFluo-4-AM and an Olympus FV300-SU laser scanning confocal microscope. A drop of cell suspension was placed on a glass coverslip and loaded with 5 μM MagFluo-4-AM for 45--60 min in the dark at room temperature. The loading solution also contained 50 μM BAPTA-AM to suppress possible changes in MagFluo-4 fluorescence due to increases in \[Ca^2+^\]~i~. After loading, PASMCs were continually superfused with PSS (2 ml/min) for 10--30 min to allow deesterification of both agents. Integral MagFluo-4 fluorescence was measured by using excitation and emission wave lengths of 488 and 505 nm, respectively. Images (256 × 256 pixels) were acquired at 0.33 Hz using Fluoview software (Olympus). Measurements were performed in Ca^2+^-free PSS containing 1 mM EGTA to inhibit Ca^2+^ influx. Data were analyzed offline with MetaMorph v.6.1 (Universal Instruments) and corrected for photobleaching, occurring at this acquisition rate under control conditions, using a monoexponential function. Fluorescence was expressed as F/F~0~ ratio, where F~0~ represents background control fluorescence.

Data analysis and statistics.
-----------------------------

Data were analyzed and presented using pClamp 8 (Axon Instruments), Microsoft Excel, and Microcal Origin 6.0 software (Microcal Software, Northampton, MA). Activation dependencies were fitted with the Levenberg-Marquardt algorithm in Origin 6.0 software. The goodness of fit was evaluated from the coefficient of determination R2 which ranged from 0.96 to 0.999. Data are expressed as means ± SE[.]{.smallcaps} The paired two-tail *t*-test was used to compare parameters obtained in control (which could be either PSS or pretreatment with another inhibitor) and test conditions in the same cell. A nonpaired *t*-test was used to compare the differences between two groups of data. When normality test failed (Shapiro-Wilk test), the Wilcoxon signed rank test and the Mann-Whitney\'s test were used for comparison of paired and nonpaired data, respectively. A one-way ANOVA with the Dunnett (equal variance) or Tamhane (nonequal variance) post hoc tests or Kruskal-Wallis for non-parametric data followed by Mann-Whitney\'s test with a Bonferroni correction were used to compare differences in half-activation potential and the *I*~Kv~ block between more than two groups of data. *P* \< 0.05 was deemed significant.

RESULTS
=======

Properties of I~Kv~ in freshly isolated rat PASMCs.
---------------------------------------------------

Kv channel currents have previously been characterized in a variety of cell types including PASMCs. *I*~Kv~ currents in the rat resistance PASMC represent a delayed rectifier type current, with fast-activating and slowly inactivation kinetics ([@r40]). [Figure 1*A*](#f1){ref-type="fig"} shows representative traces of *I*~Kv~ recorded with the voltage protocol described in [materials and methods]{.smallcaps}. The current-voltage (*I-V*) curve was constructed from the tail currents measured 2--3 ms after membrane repolarization and clearly demonstrates that *I*~Kv~ in the PASMC activates at membrane potentials positive to −50 mV and is almost fully activated at voltages positive to +20 mV ([Fig. 1*B*](#f1){ref-type="fig"}).

Mitochondrial inhibition shifts I~Kv~ activation to negative potentials and decreases I~Kv~ at positive potentials.
-------------------------------------------------------------------------------------------------------------------

The impact of inhibition of the mETC, and therefore oxidative phosphorylation, on *I*~Kv~ in PAMSC was investigated using specific inhibitors for different sites in the mETC ([Fig. 2*A*](#f2){ref-type="fig"}). Inhibitors investigated included: rotenone (inhibiting complex I), myxothiazol (inhibiting complex III proximal to the antimycin A site of action), antimycin A (inhibiting at complex III), and NaCN (acting at complex IV). The change in the half-activation potentials (determined from the fit to the Boltzmann equation) between control conditions and test conditions, subsequent to 5-min perfusion with the inhibitor, was compared. The *I-V* curve shown in [Fig. 2*B*](#f2){ref-type="fig"} highlights the change in half-activation for inhibition of complex III by antimycin A, resulting in a negative shift of −13.8 ± 2 mV (*P* \< 0.001, *n* = 9). All these mETC inhibitors caused a significant negative shift in *I*~Kv~ half-activation potentials, reflecting activation of the Kv channel currents at more negative potentials. It is worth noting that inhibiting more distal components of electron transport resulted in the largest negative shift in the half-activation potentials of *I*~Kv~ ([Fig. 2*C*](#f2){ref-type="fig"}).

Additionally, all four inhibitors decreased current amplitude at positive potentials. The representative traces shown for each inhibitor in [Fig. 3*A*](#f3){ref-type="fig"} reflect the decrease in current amplitude observed at +50 mV; the gray represents control, and the black reflects "test" conditions. The effect of inhibitors on the current amplitude was determined by the change in current density at each membrane potential in the absence and presence of the inhibitor. A representative *I-V* curve showing the effect of antimycin A on *I*~Kv~ current density is shown in [Fig. 3*B*](#f3){ref-type="fig"}. A significant decrease in current amplitude resulting from closure or inactivation of Kv channels was observed at all potentials positive to −10 mV with 56 ± 4% block observed at +50 mV (*P* \< 0.01, *n* = 9). The average decrease in *I*~Kv~ current amplitude for all inhibitors at +50 mV is shown in [Fig. 3*C*](#f3){ref-type="fig"}. Interestingly, antimycin A, which inhibits complex III, had the greatest impact on both the enhanced channel activation and decreased *I*~Kv~ amplitude ([Figs. 2](#f2){ref-type="fig"} and [3](#f3){ref-type="fig"}). No significant effect was observed on the current activation kinetics \[measured as a time constant from a single exponential fit of the current onset in response to a step membrane depolarization as previously described ([@r40])\]. For example, time constants of *I*~Kv~ activation measured at step depolarization to 0 and +50 mV in nine PASMCs were respectively equal to 8.7 ± 1.4 ms and 3.4 ± 0.5 ms in the presence of 1 μM antimycin A and 11.4 ± 1.9 ms and 3.0 ± 0.5 ms in the absence of the inhibitor.

CCCP mimics the effect of the mETC inhibitors.
----------------------------------------------

CCCP uncouples the mitochondrial electron transport by dissociating the proton gradient and thus causing mitochondrial depolarization. CCCP caused a similar change in half-activation potential reflecting a negative shift in Kv channel activation of −7.8 ± 2 mV (*P* \< 0.01, *n* = 20) ([Fig. 4*A*](#f4){ref-type="fig"}) and a decrease in current amplitude at +50 mV by 26 ± 5% (*P* \< 0.01) ([Fig. 4*B*](#f4){ref-type="fig"}).

Effects of antimycin A are specific to inhibition of the mETC.
--------------------------------------------------------------

The similarity between the effects of all mETC inhibitors and CCCP strongly suggests that the observed changes in the *I*~Kv~ parameters are mainly due to inhibition of mitochondrial function. However, since antimycin A was subsequently used as the main pharmacological tool to inhibit the mETC due to its profound effects on *I*~Kv~ characteristics, its specificity was further assessed in the presence of rotenone or myxothiazol, which act proximal to the antimycin A inhibitory site at complex III. It would be anticipated that the effects of antimycin A, if associated with inhibition of the mETC complex III, will be attenuated in the presence of proximal inhibitors due to a reduction of electron flow to complex III. Such attenuation of antimycin A-mediated increases in ROS production has been demonstrated in isolated mitochondria ([@r7], [@r17]). Similarly, cell treatment with the mitochondrial uncoupler CCCP, which disrupts the proton gradient and causes mitochondrial depolarization, should also attenuate antimycin A-mediated effects. A significant suppression of the shifts in *I*~Kv~ activation induced by antimycin A was observed following cell pretreatment with either the mETC inhibitors or CCCP; this suggests that the antimycin A-mediated effects are specific to its actions on mitochondrial electron transport ([Fig. 5](#f5){ref-type="fig"}). These results are consistent with the notion that antimycin A-mediated changes in *I*~Kv~ activation are mainly due to its inhibition of the mETC.

Effect of antimycin A on cell membrane potential.
-------------------------------------------------

The effect of antimycin A on the cell membrane potential was assessed in current clamp mode. [Figure 6*A*](#f6){ref-type="fig"} shows typical changes in the cell membrane potential upon application of 1 μM antimycin A, which caused a slowly developing membrane depolarization from −40 mV to −16 mV. The effect was completely reversible following washout of the mETC inhibitor. [Figure 6*B*](#f6){ref-type="fig"} summarizes the effect of antimycin A measured in three PASMCs.

Changes in cellular ATP concentration block the enhanced I~Kv~ at negative potentials.
--------------------------------------------------------------------------------------

Inhibition of the mETC will impair oxidative phosphorylation in mitochondria \[which may lead to changes in intracellular metabolic state and subsequent alteration in the *I*~Kv~ properties as previously suggested ([@r54])\]. To investigate whether the effects on *I*~Kv~ were due to changes in ATP production, oligomycin, an inhibitor of the ATP synthase that acts by blocking proton transport, was studied ([Fig. 7*A*](#f7){ref-type="fig"}). Oligomycin had potent effects and caused a significant negative shift in *I*~Kv~ activation ([Fig. 7*B*](#f7){ref-type="fig"}, gray bar) and a substantial decrease of 46 ± 3% (*P* \< 0.0001, *n* = 12) in *I*~Kv~ amplitude ([Fig. 7*C*](#f7){ref-type="fig"}, gray bar). These effects were comparable to those observed with antimycin A. If these oligomycin-induced changes in *I*~Kv~ characteristics are due to its inhibition of ATP production by mitochondria, then addition of 5 mM ATP to the pipette solution should inhibit the effects of oligomycin on *I*~Kv~. When PASMCs were dialyzed with 5 mM Na~2~ATP, the effect of oligomycin on *I*~Kv~ half-activation was almost completely inhibited ([Fig. 7*B*](#f7){ref-type="fig"}, black bar). The oligomycin-induced inhibition of *I*~Kv~ amplitude was also decreased, but to a lesser extent (*P* \< 0.01) ([Fig. 7*C*](#f7){ref-type="fig"}).

To investigate the possibility that antimycin A and oligomycin are acting via the same mechanism, the effects of oligomycin were studied in cells pretreated with antimycin A. Oligomycin caused an additional negative shift in *I*~Kv~ activation ([Fig. 8](#f8){ref-type="fig"}, left) and a further decrease in *I*~Kv~ amplitude ([Fig. 8](#f8){ref-type="fig"}, *right*) to that caused by antimycin A alone. These observations suggest that the effects of antimycin A are somewhat independent of oligomycin and may involve more than just an effect on mitochondrial ATP production.

Changes in cellular magnesium concentration contribute to the mitochondria-dependent dual effects on I~Kv~.
-----------------------------------------------------------------------------------------------------------

To verify that antimycin is having an effect in addition to its attenuation of ATP production, the dialysis of the cells with ATP was also investigated on the antimycin A-induced changes in *I*~Kv~ characteristics. Dialysis of the cells with either the magnesium salt of ATP (MgATP) or the disodium salt of ATP (Na~2~ATP) significantly attenuated the effects of antimycin A on the negative shift in *I*~Kv~ activation and the decrease in current amplitude ([Fig. 9](#f9){ref-type="fig"}, *A* and *B*). However, it is interesting to notice that the effects of the magnesium-conjugated ATP salt were much less effective at attenuating the effects of antimycin A. Indeed, in the presence of the magnesium salt, antimycin A still caused a 42 ± 4% (*n* = 9) decrease in current amplitude compared with 56 ± 4% (*n* = 9) in the absence of ATP and 11 ± 9% (*n* = 8) in the presence of the disodium salt.

Since ATP is a potent Mg^2+^ chelator, significant differences in the effect of the two ATP salts on the antimycin A-induced changes in *I*~Kv~ characteristics may be due to Na~2~ATP acting as a better Mg^2+^ buffer than MgATP. To investigate this, 5 mM EGTA was replaced with 5 mM EDTA, a more potent chelator of Mg^2+^ than EGTA, in the pipette solution. Under this condition, the antimycin A-mediated effects on the negative shift in *I*~Kv~ activation and the decreased current amplitude were significantly attenuated ([Fig. 9](#f9){ref-type="fig"}, *A* and *B, left*, black bars), reflecting the changes observed by dialysis of the cells with Na~2~ATP. In addition, the effect of cell dialysis with the ATP salts and the exchange of EGTA for EDTA alone shifted the half-activation potentials to more positive potentials compared with control conditions while MgATP has a half-activation potential similar to the control pipette solution ([Fig. 9*B*](#f9){ref-type="fig"}, right), again consistent with the idea that the changes in *I*~Kv~ activation may be due to the buffering capacity for magnesium.

In addition, an increase in \[MgCl~2~\] from 0.5 mM (control) to 10 mM in the pipette solution in seven PASMCs mimicked both effects of antimycin A on *I*~Kv~, demonstrating a significant shift to more negative potentials in the steady-state activation dependency with the mean half-activation potentials equal to −13.2 ± 0.6 mV (*n* = 184) and −23 ± 3.1 mV (*n* = 7, *P* \< 0.01) and a decreased current density from 133 ± 6 pA/pF (*n* = 184) to 68 ± 11 pA/pF in the control and increased pipette \[MgCl~2~\], respectively. These observations therefore support the possibility that the antimycin A-mediated modulation of *I*~Kv~ also depends on increased levels of \[Mg^2+^\]~i~.

An increase in \[Mg^2+^\]~i~, in addition to \[Ca^2+^\]~i~ in response to mitochondrial depolarization caused by mitochondrial uncouplers, has previously been demonstrated in cardiac myocytes ([@r22]) and in PC12 cells ([@r21]). However, there is no evidence that this process also occurs in PASMCs. Therefore, the effect of the mitochondrial uncoupler CCCP (2 μM) and the complex III inhibitor antimycin A (1 μM) was investigated in isolated PASMCs loaded with Mg^2+^-sensitive dye, MagFluo-4-AM, and in the presence of BAPTA-AM (to minimize \[Ca^2+^\]~i~-dependent contamination of the fluorescent signal, data not shown). Experiments were also performed in a Ca^2+^-free solution containing 1 mM EGTA. [Figure 10*A*](#f10){ref-type="fig"} illustrates the effect of CCCP on MagFluo-4 fluorescence in a representative experiment. Time dependence of changes in MagFluo-4 signal observed in the presence of CCCP and antimycin A are shown in [Fig. 10*B*](#f10){ref-type="fig"}. The effect was statistically compared 5 and 10 min after addition of the mitochondrial inhibitors ([Fig. 10*C*](#f10){ref-type="fig"}). As shown in this figure, both agents caused significant increases in \[Mg^2+^\]~i~, supporting a role of \[Mg^2+^\]~i~ in the mitochondria-mediated modulation of *I*~Kv~. Interestingly, the basal level of \[Mg^2+^\]~i~ did not recover after the removal of CCCP and antimycin A. This effect was also observed in cardiac myocytes ([@r22]).

DISCUSSION
==========

The use of paxilline (a BK~Ca~ inhibitor) and glibenclamide (a K~ATP~ channel blocker) allows effective isolation of the major voltage-dependent 4-aminopyridine-sensitive *I*~Kv~ in PASMCs, as we have previously demonstrated ([@r40]). Glibenclamide was necessary because our standard pipette solutions did not include ATP, which would minimize K~ATP~ currents. Contribution from other K^+^ channels, such as TASK or KCNQ, recently described in PASMCs ([@r13], [@r14], [@r16], [@r19]), is likely to be relatively small in proportion to the dominant whole cell *I*~Kv~. Also, TASK currents are voltage independent, whereas KCNQ-mediated currents do not inactivate, both properties that are completely different from characteristics of *I*~Kv~.

Inhibition of mitochondrial function causes a negative shift in I~Kv~ activation and decreases I~Kv~ amplitude.
---------------------------------------------------------------------------------------------------------------

A close functional relationship between Kv channels and mitochondria is supported by experiments in dialyzed PASMCs where inhibition of mitochondrial function was impaired by several inhibitors, each targeting a different point in the electron transport chain ([Fig. 2*A*](#f2){ref-type="fig"}). All these inhibitors had a dual effect on *I*~Kv~. A hyperpolarizing (or negative) shift in the steady-state activation dependency, reflecting an increase in Kv channel activation at negative membrane voltages, was observed, as demonstrated in [Fig. 2](#f2){ref-type="fig"}. A significantly decreased current amplitude occurring at membrane potentials positive to 0 mV, i.e., in the voltage range where the current activation is mostly completed, was also prominent. These effects were most potent due to inhibition of complex III by antimycin A, blocking the flow of electrons from semiquinone to ubiquinone in the Q cycle in complex III, and to oligomycin inhibiting ATP synthase by blocking its proton channel, essential for the oxidative phosphorylation of ADP to ATP.

As each inhibitor acts on a different part of mitochondrial electron transport chain and was used in the experiment at a relatively low concentration, it is highly unlikely that the observed effects were nonspecific. Furthermore, significant attenuation of the antimycin A-mediated shifts in the *I*~Kv~ activation in the presence of more proximal mETC inhibitors and CCCP ([Fig. 5](#f5){ref-type="fig"}) and significant attenuation of antimycin A-induced changes in both *I*~Kv~ activation and amplitude by intracellular ATP or EDTA ([Fig. 9](#f9){ref-type="fig"}), strongly supports this conclusion.

ATP and \[Mg^2+^\]~i~ are mitochondria-dependent effectors targeting Kv channels.
---------------------------------------------------------------------------------

Inhibition of the mETC ultimately disrupts the proton gradient across the inner mitochondrial membrane. This disruption of the proton gradient prevents the ATP production due to a lack of protons to flow through and activate the ATP synthase ([@r18]). The addition of ATP to the intracellular solution significantly attenuated the effects of both oligomycin and antimycin A on *I*~Kv~ characteristics. As oligomycin is a specific inhibitor of the ATP synthase, intracellular ATP concentrations would be significantly decreased. Addition of ATP to the pipette solution significantly attenuated the effects of oligomycin and antimycin A on *I*~Kv~ half-activation potentials. The lack of inhibition of the effect of oligomycin by preincubation with antimycin A potentially suggests that either these agents are affecting *I*~Kv~ via different mechanisms or that they act via the same mechanism with additive potency at the concentrations used in our experiments. Higher concentrations were not evaluated due to the likelihood of nonspecific actions occurring. As ATP did not completely inhibit the changes in *I*~Kv~ characteristics and due to the significant difference between the antimycin A-dependent negative shift in *I*~Kv~ half-activation in the presence of intracellular MgATP and Na~2~ATP, a significant attenuation of its effect in cells dialyzed with EDTA, and the ability of increased \[Mg^2+^\]~i~ to cause a negative shift in the *I*~Kv~ activation, an involvement of \[Mg^2+^\]~i~ is strongly indicated. Our, and other, laboratories have previously demonstrated a \[Mg^2+^\]~i~-dependent shift to more negative potentials in the steady-state activation of Kv1.5 and Kv2.1 channels ([@r8], [@r44]). Both Kv channel subtypes are proposed as molecular candidates for *I*~Kv~ in native PASMCs (reviewed in Ref. [@r9]). Confirmation of an involvement of \[Mg^2+^\]~i~ in the regulation of *I*~Kv~ is provided by a significant elevation of \[Mg^2+^\]~i~ in response to CCCP and antimycin A in single PASMCs. Increases in \[Mg^2+^\]~i~ in response to mitochondrial inhibition and to hypoxia have previously been reported in cardiac myocytes ([@r5], [@r22], [@r39]); this is the first report of such phenomenon in the pulmonary vasculature. Contribution of \[Ca^2+^\]~i~ \[previously suggested to play a role in the modulation of *I*~Kv~ ([@r35])\] to the observed effects is unlikely because: *1*) data were obtained from cells where free \[Ca^2+^\]~i~ (∼10 nM) was strongly buffered with 10 mM EGTA; and *2*) cell dialysis with 220 nM Ca^2+^ alone caused a significant rightward shift in *I*~Kv~ activation (unpublished observations), an effect opposite to that described in this paper.

Elevation of \[Mg^2+^\]~i~ as a result of inhibition of the mETC may be explained by decreased oxidative phosphorylation leading to a reduced level of ATP and resulting in an increased ADP-to-ATP ratio. Since ADP is a less potent Mg^2+^ chelator than ATP, \[Mg^2+^\]~i~ would increase. The ability of the mitochondrial inhibitors used and CCCP to cause a hyperpolarizing shift in the *I*~Kv~ activation supports this suggestion. Also, \[Mg^2+^\]~i~ may be additionally increased when mitochondria are depolarized as mitochondrial uptake of Mg^2+^ is directly linked to the proton motive force ([@r20]). Based on evidence obtained in isolated mitochondria, Mg^2+^ efflux can be increased in depolarized mitochondria ([@r21]) or the rate of ATP hydrolysis by the ATP synthase (working in the reverse mode to restore the mitochondrial membrane potential) could also be increased ([@r11]). It is currently difficult to accurately evaluate changes in ATP or Mg^2+^ concentration in submembrane compartments in intact cells. Nevertheless, changes in the Kv channel parameters can serve as useful markers to evaluate changes in the subplasmalemmal environment in the close vicinity to the channel in PASMCs. Indeed, K~ATP~ channels and BK~Ca~ channels have been similarly used as probes to assess changes in ATP and \[Ca^2+^\]~i~ concentrations, respectively, directly beneath the plasma membrane ([@r15], [@r43]).

Mitochondria-mediated decrease in I~Kv~ amplitude.
--------------------------------------------------

In contrast to the changes in *I*~Kv~ activation, the decrease in *I*~Kv~ amplitude was significantly attenuated only by buffering Mg^2+^ ([Fig. 9*A*](#f9){ref-type="fig"}). Such observations suggest that an increase in \[Mg^2+^\]~i~ could also be responsible for the *I*~Kv~ block at positive membrane potentials and is also supported by the observation that the current density was significantly reduced when cells were dialyzed with 10 mM Mg^2+^ compared with control. The ability of \[Mg^2+^\]~i~ to inhibit of variety of ion channels, including Kv channels, is well recognized (reviewed in Ref. [@r2]). The mechanism of the block of Kv channels by \[Mg^2+^\]~i~ is thought to be a result of the direct occlusion of the channel pore and interference with K^+^ efflux and is therefore most prominent at positive potentials ([@r8], [@r24], [@r25]). Interestingly, \[Mg^2+^\]~i~ was shown to have a greater inhibitory effect on the delayed rectifier Kv channel, like the one expressed in PASMCs, than rapidly inactivating A-type Kv currents ([@r25]). This may contribute to specificity of \[Mg^2+^\]~i~-dependent effects in different preparations.

Several other mechanisms may contribute to the dual effects of mitochondrial inhibition on *I*~Kv~ reported in this paper; investigation of these was beyond the scope of this manuscript. Antimycin itself binds to the Qi site of complex III (the cytochrome *c* oxidoreductase enzyme); cytochrome *c* is thus known to be activated by antimycin A, released from the mitochondria, and has recently been shown to activate Kv channels in PASMCs, increasing *I*~Kv~ ([@r34]). This process is, however, unlikely to occur within the time frame used in our experiments as in isolated mitochondria neither rotenone, antimycin A, cyanide, nor FCCP were able to induce cytochrome *c* release or mitochondrial swelling following 10-min pretreatment ([@r23]). Furthermore, complex III is a major site for the free radical, superoxide to be produced, and antimycin A is known to increase production of reactive oxygen species ([@r6]). Such reactive oxygen species of mitochondrial origin have been suggested to be the effectors mediating the effects of hypoxia on Kv channels (reviewed in Ref. [@r28]). It is worth noting that due to changes in the proton motive force and a nonlinear link between the mitochondrial membrane potential and mitochondrial superoxide production ([@r29]), a potential interaction between mitochondrial reactive oxygen species and \[Mg^2+^\]~i~ is likely to occur, and further studies are necessary to establish the role reactive oxygen species could play in Mg^2+^-mediated regulation of Kv channels in PASMCs.

The depolarizing effect of antimycin A on the cell membrane potential ([Fig. 6](#f6){ref-type="fig"}) suggests that mitochondria-dependent inhibition of *I*~Kv~ could play an important role in the regulation of the cell membrane potential in PASMCs. A slow time course of antimycin A-dependent depolarization is different from the relatively rapid depolarizing effect of the nonselective inhibitor of Kv channels 4-aminopyridine reported previously by several groups ([@r38], [@r41], [@r54]). It is possible that such differences in the onset of membrane depolarization in response to mETC inhibition and the direct inhibition of Kv currents with 4-aminopyridine are due to mitochondria-mediated changes in the steady-state activation of *I*~Kv~, which would oppose membrane depolarization.

In conclusion, our data comprehensively demonstrate a close functional association between the Kv channels and the putative oxygen sensor mitochondria in PASMCs. Mitochondria-dependent changes in intracellular ATP and Mg^2+^ concentrations significantly contribute as functional effectors in this process. A potential role for these mechanisms in the unique response of PASMC to hypoxia may exist and requires further experimentation.
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![Kv channel currents recorded from freshly isolated rat small pulmonary arterial smooth muscle cells (PASMC). *A*: a representative current trace recorded using the activation protocol (*top*). *B*: current-voltage (*I-V*) relationship for activation derived from the tail current measured from the example shown in *A*. Solid lines represent the fit to the Boltzmann equation with the half-activation potential (dashed line) mV and the slope factor equal to −16.9 and 8.8 mV, respectively. Cell membrane capacitance (C~m~) was equal to 14.6 pF.](zh50070852340001){#f1}

![Inhibition of the mitochondrial electron transport chain (mETC) shifts *I*~Kv~ activation to more negative potentials. *A*: schematic depicting the mETC. Sites of inhibition with specific inhibitors are indicated. *B*: normalized *I*~Kv(tail)~ activation in control and in the presence of 1 μM antimycin A (*n* = 9). *I*~Kv(tail)~ was measured at 2--3 ms after a test potential, normalized and fitted to the Boltzmann equation as described in [materials and methods]{.smallcaps}. Solid lines were drawn with the half-activation potentials equal to −11.3 and −22 mV (dashed lines) and the slope factors equal to 10.8 and 10.4 mV for control and antimycin A, respectively. *C*: change in the half-activation potential between control and in the presence of the indicated inhibitor (*n* = 22, 10, 9, and 14, respectively). \*\*\**P* \< 0.001.](zh50070852340002){#f2}

![Inhibition of the mETC decreases *I*~Kv~ amplitude at positive potentials. *A*: representative paired current traces at +50 mV for control (gray and marked as C) and in the presence of the indicated mETC inhibitors (black and marked as Rot, Myx, Ant, and cyanide for rotenone, myxothiazol, antimycin A, and NaCN, respectively). Cell capacitance was equal to 11.1 pF (rotenone), 14.2 pF (myxothiazol), 12.6 pF (antimycin A), and 14.7 pF (NaCN). Vertical and horizontal bars are equal to 1 nA and 100 ms, respectively. *B*: *I*~Kv~ current density in control and in the presence of 1 μM antimycin A (*n* = 9). *C*: decrease in the Kv current amplitude at +50 mV after 5-min perfusion with the indicated inhibitor (*n* = 22, 10, 9, and 14, respectively). \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001.](zh50070852340003){#f3}

![Dissociation of the mitochondrial proton gradient with CCCP mimics the dual effect of the mitochondrial inhibitors. CCCP shifts *I*~Kv~ activation to more negative potentials and decreases the current amplitude at positive potentials. *A*: normalized *I*~Kv(tail)~ in control and in the presence of CCCP (*left*) and the average negative shift in the half-activation potential (*right*, *n* = 20). Solid lines were drawn in accordance with the Boltzmann equation with the half-activation potentials equal to −13.7 and −22.6 mV (dashed lines) and the slope factors equal to 9.9 and 10.0 mV for control and CCCP, respectively. *B*: representative current trace at +50 mV in control (gray) and in the presence of CCCP (black, *left*) and the average changes in the current amplitude at +50 mV (*right*, *n* = 20). C~m~ = 8.8 pF. \*\**P* \< 0.01.](zh50070852340004){#f4}

![The effect of antimycin A on the negative shift in *I*~Kv~ activation is specific to its inhibition of the mETC. Proximal mETC inhibitors rotenone and myxothiazol (1 μM) and the mitochondrial uncoupler CCCP (2 μM) inhibit the antimycin A-induced (gray) negative shift in *I*~Kv~ half-activation in 8, 7, and 8 PASMCs, respectively. Cells were preincubated with each inhibitor for 5 min before recording the "control" *I-V*. Cells were then superfused with 1 μM antimycin A for 5 min before recording the test *I-V*. Experiments were performed in the whole cell configuration. The significance of the inhibition of the antimycin-induced change in half-activation is represented by the gray bar. \#\#*P* \< 0.01, \#\#\#*P* \< 0.001.](zh50070852340005){#f5}

![Antimycin A slowly and reversibly depolarizes PASMCs. *A*: representative recording of the cell membrane potential in the current clamp mode. Cell capacitance was equal to 12.3 pF. *B*: summary of the antimycin A-induced changes in the cell membrane potential in 3 PASMCs. \**P* \< 0.05 compared with control.](zh50070852340006){#f6}

![Inhibition of the ATP transporter with oligomycin mimics the effects of the inhibition of the mETC on *I*~Kv~ activation and amplitude. *A*: schematic depicting the mitochondrial electron transport chain including ATP production by complex V. Sites of inhibition with specific inhibitors are indicated. *B*: effect of oligomycin (gray) on the half-activation (*left*, *n* = 12) and *I*~Kv~ amplitude at +50 mV (*right*, *n* = 12). Dialysis of the cells with ATP (5 mM Na~2~ATP in the pipette solution) inhibited the changes in *I*~Kv~ (black) (*n* = 6). \#\#*P* \< 0.01, indicating significance of the inhibitory effect of Na~2~ATP compared with the control (gray bars).](zh50070852340007){#f7}

![The effects of antimycin and oligomycin on *I*~Kv~ are additive. Effect of preincubation with antimycin A on the oligomycin-induced changes in half-activation potential and the decrease in current amplitude (black columns, *n* = 7). For successive treatment, cells were perfused with antimycin A for 5 min and a control *I-V* was recorded. Cells were then perfused with antimycin A and oligomycin for 5 min before recording a "test" *I-V*. Oligomycin-induced changes in the presence of antimycin A was measured as the difference between the test and control recordings. Gray columns show the effects of oligomycin alone for comparison (*n* = 12). \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001.](zh50070852340008){#f8}

![Changes in intracellular magnesium concentration also contribute to the effects of the mETC inhibition on *I*~Kv~. Effect of intracellular Na~2~ATP (*n* = 8), MgATP (*n* = 9), and EDTA (*n* = 8) (no MgCl~2~ was added to the pipette solutions) on antimycin A induced changes in half-activation potential and a decrease in *I*~Kv~ amplitude at +50 mV (*A*). The effect of antimycin A under control conditions is shown in gray for comparison. *B*: absolute half-activation potential values due to change in each pipette solution as indicated (*n* = 184, 9, 22, and 25, respectively). \#*P* \< 0.05, \#\#*P* \< 0.01, and \#\#\#*P* \< 0.001. \#Significance of the inhibitory effect in each pipette solution compared with the control.](zh50070852340009){#f9}

![Inhibition of the mETC increases \[Mg^2+^\]~i~ in single PASMCs. *A*: representative transmitted light (*left*) and fluorescence images of a PASMC loaded with MagFluo-4 in response to 2 μM CCCP at the time of application indicated above. *B*: time dependence of changes in the intensity of the MagFluo-4 fluorescence expressed as F/F~0~. Arrows indicate time points where images shown in *A* were taken. *C*: averaged effect of CCCP and antimycin A on \[Mg^2+^\]~i~ at 5- and 10-min period (*n* = 7 and 7, respectively). \**P* \< 0.05, \*\**P* \< 0.01.](zh50070852340010){#f10}
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